These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24186074)

  • 1. Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis.
    Wang L; Wang Z; Gao X; Li X; Sun X; Liu C
    Tumour Biol; 2014 Feb; 35(2):1149-55. PubMed ID: 24186074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.
    Wu Y; Fu H; Zhang H; Huang H; Chen M; Zhang L; Yang H; Qin D
    Tumour Biol; 2014 Jul; 35(7):6913-8. PubMed ID: 24737585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between
    Thakur N; Kumari S; Mehrotra R
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
    Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
    PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 polymorphism and oral cancer: a meta-analysis.
    Wang W; Zhao Y; Yang J; Lin B; Gu H; Cao X; Ge L
    Mol Biol Rep; 2013 Jan; 40(1):87-95. PubMed ID: 23111452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
    Xie M; Zhao F; Zou X; Jin S; Xiong S
    Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
    Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
    Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
    Chen B; Cao L; Yang P; Zhou Y; Wu XT
    Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
    Hu YY; Zheng R; Guo C; Niu YM
    Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis.
    Meng Y; Zhang C; Zhou X
    Onco Targets Ther; 2016; 9():367-76. PubMed ID: 26855585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
    Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
    Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis.
    Akhter N; Alzahrani FA; Dar SA; Wahid M; Sattar RSA; Hussain S; Haque S; Ansari SA; Jawed A; Mandal RK; Almalki S; Alharbi RA; Husain SA
    J Cell Biochem; 2019 Oct; 120(10):16452-16466. PubMed ID: 31243808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls.
    Cui J; Shen L; Wang Y
    Asian Pac J Cancer Prev; 2012; 13(10):5023-5. PubMed ID: 23244103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.
    Zhou C; An H; Hu M; Liu Q; Geng P; Xu J; Sun B; Liu C
    Tumour Biol; 2013 Dec; 34(6):3831-7. PubMed ID: 23873109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis.
    Tang C; Wang Z; Yu J; Wu Y; Zhu Z; Chen N
    Med Oncol; 2011 Dec; 28(4):1319-24. PubMed ID: 20443083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCND1 G870A polymorphism and colorectal cancer risk: An updated meta-analysis.
    Xu XM; Ni XB; Yang GL; Luo ZG; Niu YM; Shen M
    Mol Clin Oncol; 2016 Jun; 4(6):1078-1084. PubMed ID: 27284448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations.
    Zhang LQ; Huang XE; Wang J; Shang JQ; Bai J; Liu FY; Guan X; Zhou JN
    Asian Pac J Cancer Prev; 2011; 12(1):81-5. PubMed ID: 21517236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between CCR2-V64I polymorphism and cancer risk: a meta-analysis.
    Huang Y; Chen H; Wang J; Bunjhoo H; Xiong W; Xu Y; Zhao J
    Gene; 2013 Jul; 524(1):54-8. PubMed ID: 23612252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCND1 G870A polymorphism is associated with increased risk of colorectal cancer, especially for sporadic colorectal cancer and in Caucasians: a meta-analysis.
    Yang J; Zhang G; Chen J
    Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):169-77. PubMed ID: 22322158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the G870A polymorphism of Cyclin D1 gene and glioma risk.
    Zong H; Cao L; Ma C; Zhao J; Ming X; Shang M; Xu H
    Tumour Biol; 2014 Aug; 35(8):8095-101. PubMed ID: 24840634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.